<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02370719</url>
  </required_header>
  <id_info>
    <org_study_id>BantII</org_study_id>
    <nct_id>NCT02370719</nct_id>
  </id_info>
  <brief_title>Evaluation of an mHealth Behavioural Intervention for the Self-Management for Type 2 Diabetes</brief_title>
  <official_title>Evaluation of an mHealth Behavioural Intervention for the Self-Management for Type 2 Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mount Sinai Hospital, New York</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Toronto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate a patient-centered diabetes self-management mobile
      application (app), which was developed with feedback from both patients and healthcare
      providers. During the 12 month randomized control trial, participants in the intervention
      group will be provided with a mobile phone and commercial home medical devices, such as a
      weight scale, glucometer and activity monitor. The measurements taken from the medical
      devices will wirelessly transfer to the mobile phone, where the app will assess the data and
      provide patients with actionable self-management knowledge. The proposed intervention may be
      helpful in increasing adherence to recommended self-care practices, improving self-efficacy,
      and enhancing the overall patient experience.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in HbA1c from baseline to 12 months</measure>
    <time_frame>Baseline, 3, 6, 9 and 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>Baseline, 3, 6, 9 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>Baseline, 3, 6, 9 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cholesterol (LDL and total)</measure>
    <time_frame>Baseline, 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication changes</measure>
    <time_frame>3, 6, 9 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycemic excursions</measure>
    <time_frame>3, 6, 9 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BMI</measure>
    <time_frame>Baseline, 3, 6, 9 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes Distress Scale</measure>
    <time_frame>Baseline, 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes Empowerment Scale</measure>
    <time_frame>Baseline, 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Summary of Diabetes Self-Care Activities</measure>
    <time_frame>Baseline, 6 and 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Intervention Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mobile application plus standard of care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard of care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mobile application for diabetes self-management</intervention_name>
    <arm_group_label>Intervention Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  English-speaking individuals

          -  Diagnosed with non-insulin requiring type 2 diabetes

          -  Outpatients

          -  Baseline A1c of 7.5% or higher

        Exclusion Criteria:

          -  Patients who are deemed unable to use a mobile phone (e.g. due to vision problems),
             and/or to comply with home monitoring (e.g. suffering from anxiety or depression)

          -  Diabetes duration &lt;1 year
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph A Cafazzo, PEng, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Health Network, Toronto</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shivani Goyal, BEng, MScA</last_name>
    <phone>6479793309</phone>
    <email>sgoyal@ehealhinnovation.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T3L9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Warren McIsaac, MD</last_name>
      <phone>4165864800</phone>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 18, 2015</study_first_submitted>
  <study_first_submitted_qc>February 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2015</study_first_posted>
  <last_update_submitted>December 21, 2015</last_update_submitted>
  <last_update_submitted_qc>December 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Health Network, Toronto</investigator_affiliation>
    <investigator_full_name>Joseph Cafazzo</investigator_full_name>
    <investigator_title>Senior Director</investigator_title>
  </responsible_party>
  <keyword>Diabetes mellitus</keyword>
  <keyword>Randomized controlled trial</keyword>
  <keyword>Primary care</keyword>
  <keyword>Physical activity</keyword>
  <keyword>Lifestyle</keyword>
  <keyword>Blood glucose</keyword>
  <keyword>Mobile health</keyword>
  <keyword>Hb A1c</keyword>
  <keyword>Self-management</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

